Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:



Google News for ABBVIE:

Seeking Alpha - 3 days ago
AbbVie: Remarkable 700% Return Potential Over Next Decade ...
According to Dividend Sensei, AbbVie (ABBV) is the Apple of the pharma world. Thanks to a powerful pipeline and great management it has ...
Top Stocks News (press release)
Is AbbVie Inc (NYSE:ABBV) A Smart Pick For Income Investors?
Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. AbbVie Inc (NYSE:ABBV) has ...
Global Export Lines (press release)
Stocks stocks you should always put money on: AbbVie Inc., (NYSE ...
Technical Analysis of AbbVie Inc.: Looking into the profitability ratios of ABBV stock, the shareholder will find its ROE, ROA and ROI standing at ...
Nyse NewsToday (press release)
Enrapturing Stocks: AbbVie Inc. (NYSE: ABBV)
On Friday, Shares of AbbVie Inc. (NYSE: ABBV) generated a change of ... ABBV is an exciting player in the Healthcare space, with a center of ...
Simply Wall St - 5 days ago
AbbVie's Future Is Looking Shaky
AbbVie Inc. (ABBV), though still a new company within the healthcare space, having been founded in 2013, the team has been together for ...
Top Stocks News (press release)
AbbVie (ABBV) Enters Clinical Research Collaboration with Tolero ...
AbbVie (NYSE: ABBV) has entered into a clinical research collaboration with Tolero Pharmaceuticals, Inc. exploring the potential of ...
News Room Alert (press release)
Gets Its Catalyst And Trades Up: Ameren Corporation (AEE), AbbVie ...
Taking a look at the current stock price for AbbVie Inc. (NYSE:ABBV), we could notice that the shares are trading close to the $98.22 level.
NMSU Nеws
AbbVie (ABBV) Tops Q2 Earnings and Revenues, View Up
North Chicago, IL-based AbbVie Inc. (ABBV - Free Report) is best known for its autoimmune disease drug, Humira. AbbVie's flagship product ...
Global Export Lines (press release) - 3 hours ago
AbbVie (ABBV) Beats Q2 Earnings and Revenue Estimates
AbbVie, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $8.28 billion for the quarter ended June 2018, ...
News Room Alert (press release) - 3 hours ago
Principia Biopharma readies IPO
In June 2017, it inked a collaboration agreement with AbbVie (NYSE:ABBV) for the research and development of oral immunoproteasome ...


Back